Indian J Pharm Close
 

Figure 7: (a) A: 3-year overall survival for B-acute lymphoblastic leukemia on ICiCLe Pilot (n = 713). (b) 3-year event-free survival for B-acute lymphoblastic leukemia on ICiCLe (n = 713)

Figure 7: (a) A: 3-year overall survival for B-acute lymphoblastic leukemia on ICiCLe Pilot (<b>n</b> = 713). (b) 3-year event-free survival for B-acute lymphoblastic leukemia on ICiCLe (<b>n</b> = 713)